Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot Study of Estradiol-Receptor Blockade in Older Adults
NCT02271282Phase 1Completed
- Sponsor
- Mayo Clinic
- Start
- Dec 2014
- Primary completion
- May 2016
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of toremifene, sponsored by Mayo Clinic. Primary endpoint: Summed mass of growth hormone over 10 hours at 10 days. Started Dec 2014; status: completed.
02
Drugs
toremifene
Beyond the preview
Go deeper on NCT02271282.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02271282.